| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 629 | 2021 |
| Prevalence and risk factors for canine epilepsy of unknown origin in the UK L Kearsley‐Fleet, DG O'neill, HA Volk, DB Church, DC Brodbelt Veterinary Record 172 (13), 338-338, 2013 | 230 | 2013 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 208 | 2021 |
| Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry PM Machado, S Lawson-Tovey, A Strangfeld, EF Mateus, KL Hyrich, ... Annals of the rheumatic diseases 81 (5), 695-709, 2022 | 163 | 2022 |
| Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis L Kearsley-Fleet, R Davies, D De Cock, KD Watson, M Lunt, MH Buch, ... Annals of the rheumatic diseases 77 (10), 1405-1412, 2018 | 151 | 2018 |
| The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology … L Silva-Fernández, M Lunt, L Kearsley-Fleet, KD Watson, WG Dixon, ... Rheumatology 55 (11), 2033-2039, 2016 | 90 | 2016 |
| How common is remission in juvenile idiopathic arthritis: a systematic review SJW Shoop-Worrall, L Kearsley-Fleet, W Thomson, SMM Verstappen, ... Seminars in arthritis and rheumatism 47 (3), 331-337, 2017 | 87 | 2017 |
| Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance MF Ugarte-Gil, GS Alarcón, Z Izadi, A Duarte-García, ... Annals of the rheumatic diseases 81 (7), 970-978, 2022 | 68 | 2022 |
| Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the'JAK-pot'collaboration K Lauper, M Ludici, D Mongin, SA Bergstra, D Choquette, C Codreanu, ... Annals of the rheumatic diseases, annrheumdis-2022-222586, 2022 | 54 | 2022 |
| Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the … L Kearsley-Fleet, R Davies, M Lunt, TR Southwood, KL Hyrich Rheumatology 55 (5), 840-847, 2016 | 54 | 2016 |
| Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and … R Davies, TR Southwood, L Kearsley‐Fleet, M Lunt, KL Hyrich, ... Arthritis & Rheumatology 67 (9), 2487-2494, 2015 | 51 | 2015 |
| Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective … SE Sattui, R Conway, MS Putman, AM Seet, MA Gianfrancesco, K Beins, ... The Lancet Rheumatology 3 (12), e855-e864, 2021 | 50 | 2021 |
| Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology … KM Fagerli, L Kearsley-Fleet, LK Mercer, K Watson, J Packham, ... Rheumatology 58 (1), 80-85, 2019 | 49 | 2019 |
| Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register KM Fagerli, L Kearsley-Fleet, KD Watson, J Packham, DPM Symmons, ... RMD open 4 (1), e000596, 2018 | 48 | 2018 |
| Factors associated with choice of biologic among children with juvenile idiopathic arthritis: results from two UK paediatric biologic registers L Kearsley-Fleet, R Davies, E Baildam, MW Beresford, HE Foster, ... Rheumatology 55 (9), 1556-1565, 2016 | 48 | 2016 |
| Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS) F McErlane, R Carrasco, L Kearsley-Fleet, EM Baildam, LR Wedderburn, ... Seminars in Arthritis and rheumatism 48 (1), 53-60, 2018 | 46 | 2018 |
| Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for … M Kihara, R Davies, L Kearsley-Fleet, KD Watson, M Lunt, DPM Symmons, ... Clinical rheumatology 36, 241-250, 2017 | 43 | 2017 |
| A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities T Beukelman, J Anink, L Berntson, C Duffy, JA Ellis, M Glerup, J Guzman, ... Pediatric Rheumatology 15, 1-9, 2017 | 40 | 2017 |
| Long-term persistence with rituximab in patients with rheumatoid arthritis AGS Oldroyd, DPM Symmons, JC Sergeant, L Kearsley-Fleet, K Watson, ... Rheumatology 57 (6), 1089-1096, 2018 | 39 | 2018 |
| Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA M Jani, WG Dixon, L Kersley-Fleet, IN Bruce, H Chinoy, A Barton, M Lunt, ... RMD open 3 (1), e000314, 2017 | 35 | 2017 |
Stephanie Shoop-WorrallUniversity of ManchesterVerified email at postgrad.manchester.ac.uk
